EAST ST. LOUIS, Ill. - Bayer HealthCare Pharmaceuticals Inc. will pay $24 million to resolve claims of plaintiffs who allege that they developed gallbladder disease or underwent gallbladder surgery as a result of using Yasmin or Yaz drospirenone-containing birth control pills, according to a March 15 order and settlement agreement filed in a federal multidistrict litigation court (In Re: Yasmin and Yaz $(Drospirenone$) Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2100...(read more)![]()
↧